Literature DB >> 19185235

Triamcinolone-assisted vitrectomy in pediatric cataract surgery.

Sajani K Shah1, Vaishali Vasavada, Mamidipudi R Praveen, Abhay R Vasavada, Rupal H Trivedi, Nirmit V Dixit.   

Abstract

We describe a technique to manage anterior vitreous face disturbance that may occur during performance of a manual posterior continuous curvilinear capsulorhexis (PCCC) in pediatric eyes. The technique renders the vitreous visible to the anterior segment surgeon and ensures a thorough and complete anterior vitrectomy in congenital cataract surgery after a manual PCCC using preservative-free triamcinolone acetonide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185235     DOI: 10.1016/j.jcrs.2008.10.037

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification.

Authors:  Arnaud Sauer; Tristan Bourcier; David Gaucher; Ermanno Candolfi; Claude Speeg-Schatz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-12       Impact factor: 3.117

2.  Intraoperative usefulness and postoperative results of the endoilluminator for performing primary posterior capsulectomy and anterior vitrectomy during pediatric cataract surgery.

Authors:  J Matalia; H Anaspure; B K Shetty; H Matalia
Journal:  Eye (Lond)       Date:  2014-06-20       Impact factor: 3.775

3.  Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas.

Authors:  Tanuj Dada; Shibal Bhartiya; Murugesan Vanathi; Anita Panda
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

4.  Impact of fluidic parameters during phacoemulsification on the anterior vitreous face behavior: Experimental study.

Authors:  Vaishali Vasavada; Samaresh Srivastava; Viraj Vasavada; Shail Vasavada; Abhay R Vasavada; Aditya Sudhalkar; Alper Bilgic
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.